Shalby Limited (SHALBY) - Total Liabilities
Based on the latest financial reports, Shalby Limited (SHALBY) has total liabilities worth Rs8.33 Billion INR (≈ $90.13 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Shalby Limited (SHALBY) equity growth momentum to track the company's year-over-year net asset growth rate.
Shalby Limited - Total Liabilities Trend (2012–2026)
This chart illustrates how Shalby Limited's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Shalby Limited to measure how efficiently the company converts operating cash flow to free cash.
Shalby Limited Competitors by Total Liabilities
The table below lists competitors of Shalby Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ONWARD MEDICAL BV EO -12
F:63E
|
Germany | €29.24 Million |
|
5paisa Capital Ltd
NSE:5PAISA
|
India | Rs12.58 Billion |
|
Servet Gayrimenkul Yatirim Ortakligi AS
IS:SRVGY
|
Turkey | TL10.36 Billion |
|
Hi-Tech Pipes Limited
NSE:HITECH
|
India | Rs6.90 Billion |
|
Avantium Holding BV
AS:AVTX
|
Netherlands | €206.57 Million |
|
KlaraBo Sverige AB Series B
ST:KLARA-B
|
Sweden | Skr6.04 Billion |
|
Akwel SA
PA:AKW
|
France | €193.97 Million |
|
Taigen Biopharmaceuticals Holdings Ltd
TWO:4157
|
Taiwan | NT$92.38 Million |
Liability Composition Analysis (2012–2026)
This chart breaks down Shalby Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Shalby Limited.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shalby Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shalby Limited (2012–2026)
The table below shows the annual total liabilities of Shalby Limited from 2012 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs8.33 Billion ≈ $90.13 Million |
+17.66% |
| 2025-03-31 | Rs7.08 Billion ≈ $76.60 Million |
+18.10% |
| 2024-03-31 | Rs6.00 Billion ≈ $64.86 Million |
+69.54% |
| 2023-03-31 | Rs3.54 Billion ≈ $38.26 Million |
+11.47% |
| 2022-03-31 | Rs3.17 Billion ≈ $34.32 Million |
+95.95% |
| 2021-03-31 | Rs1.62 Billion ≈ $17.51 Million |
-3.26% |
| 2020-03-31 | Rs1.67 Billion ≈ $18.11 Million |
+5.08% |
| 2019-03-31 | Rs1.59 Billion ≈ $17.23 Million |
-23.45% |
| 2018-03-31 | Rs2.08 Billion ≈ $22.51 Million |
-52.99% |
| 2017-03-31 | Rs4.43 Billion ≈ $47.88 Million |
+48.47% |
| 2016-03-31 | Rs2.98 Billion ≈ $32.25 Million |
+65.12% |
| 2015-03-31 | Rs1.81 Billion ≈ $19.53 Million |
+145.93% |
| 2014-03-31 | Rs734.29 Million ≈ $7.94 Million |
+58.38% |
| 2013-03-31 | Rs463.63 Million ≈ $5.01 Million |
+203.58% |
| 2012-03-31 | Rs152.72 Million ≈ $1.65 Million |
-- |
About Shalby Limited
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology servic… Read more